Solana Company
NASDAQ:HSDTMedical - Devices
+$0.01 today
- Market cap
- $95.17M
- Beta
- 1.03
- P/E (TTM)
- -0.9
- EPS (TTM)
- -$1.78
Volume 0.23M
Average 0.38M
HSDT Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Solana CompanyNASDAQ: HSDT
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization remains negative
Q1 FY2026 depreciation & amortization was $0, compared with $8K a year earlier. Trailing-twelve-month depreciation & amortization was $672K. Over 3 fiscal years it compounded at +38.7% a year.
Context
- Depreciation & amortization amounted to 11.3% of revenue in FY2025, down 0.2 pp from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly depreciation & amortization holds near $0 or moves back toward the trailing-twelve-month quarterly average of $168K.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 680K USD
- Year-over-year change
- +1033.3%
- 4-year CAGR
- +21.5%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 680K | +1033.3% |
| FY2024 | 2024-12-31 | 60K | -63.0% |
| FY2023 | 2023-12-31 | 162K | -36.5% |
| FY2022 | 2022-12-31 | 255K | -18.3% |
| FY2021 | 2021-12-31 | 312K | — |
Depreciation & Amortization vs competitors
How HSDT compares with its peers on the latest reported figures
- HSDT's LTM Mar 2026 depreciation & amortization of $672K is the 9th highest of the 11 companies compared; the peer median is $3.19M.
- Its year-over-year change of +1192.3% is the highest of 11, against a peer median of +1.0%.
- Depreciation & amortization amounts to 7.0% of revenue for HSDT, versus a peer median of 4.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $21.08M | +133.7% | +51.8% | 14.5% | |
| LTM Mar 2026 | $20.37M | -2.6% | -4.2% | 5.8% | |
| LTM Mar 2026 | $13.23M | +2.4% | -0.2% | 9.3% | |
| LTM Dec 2025 | $11.7M | -0.3% | +0.5% | 89.8% | |
| LTM Mar 2026 | $3.65M | +35.4% | +111.4% | 589.8% | |
| LTM Mar 2026 | $2.74M | -56.6% | -11.6% | 2.3% | |
| LTM Mar 2026 | $1.59M | +32.3% | +10.5% | 3.6% | |
| LTM Mar 2026 | $1.2M | +21.9% | +23.1% | 1.7% | |
| LTM Mar 2026 | $672K | +1192.3% | +38.7% | 7.0% | |
| LTM Mar 2026 | $589K | -20.5% | +14.8% | 1.3% | |
| LTM Mar 2026 | $499.7K | -57.0% | -29.2% | 2.6% | |
| Peer median (excluding HSDT) | $3.19M | +1.0% | +5.5% | 4.7% | |
Competitors are the stored peer set for HSDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 522K | 787K | 644K | 520K | 6.02M |
| Cost of Revenue | 298K | 463K | 583K | 582K | 500K |
| Gross Profit | 224K | 324K | 61K | (62K) | 5.52M |
| Gross Margin | 42.9% | 41.2% | 9.5% | -11.9% | 91.7% |
| Research & Development | 5.99M | 4.26M | 2.94M | 3.66M | 3.51M |
| Selling, General & Admin | 12.18M | 10.64M | 9.27M | 10.12M | 23.13M |
| Operating Expenses | 18.37M | 15.84M | 12.49M | 13.84M | 26.64M |
| Depreciation & Amortization | 312K | 255K | 162K | 60K | 680K |
| EBITDA | (17.82M) | (14.5M) | (12.11M) | (13.8M) | (39.58M) |
| EBITDA Margin | -3413.8% | -1842.9% | -1880.0% | -2654.4% | -657.7% |
| Operating Income | (18.14M) | (15.52M) | (12.43M) | (13.9M) | (21.12M) |
| Operating Margin | -3475.5% | -1971.5% | -1929.8% | -2673.7% | -351.0% |
| Interest Income | 0 | 0 | 257K | 0 | 0 |
| Interest Expense | 0 | 834K | 0 | 17K | 635K |
| Other Income / Expenses | 10K | 1.44M | 3.58M | 2.16M | (19.77M) |
| Income Before Tax | (18.13M) | (14.07M) | (8.85M) | (11.74M) | (40.89M) |
| Pre-Tax Margin | -3473.6% | -1788.1% | -1374.2% | -2258.1% | -679.6% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (18.13M) | (14.07M) | (8.85M) | (11.74M) | (40.89M) |
| Net Margin | -3473.6% | -1788.1% | -1374.2% | -2258.1% | -679.6% |
| EPS (Basic) | (184.51) | (26.06) | (7.28) | (4.33) | (1.85) |
| EPS (Diluted) | (184.51) | (26.06) | (7.28) | (4.33) | (1.85) |
| Weighted Avg Shares | 98.27K | 539.89K | 1.22M | 2.71M | 22.05M |
| Weighted Avg Shares (Diluted) | 98.27K | 539.89K | 1.22M | 2.71M | 22.05M |
Solana Company
NASDAQ:HSDT
Intrinsic Alpha fair value
Locked
Current Price
$1.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.